|
Re: insufficient her2 testing--not enough patients given possibility of benefiting f
RLS,
An interesting term, satellite tumor! It really matters not whether or how the second came from the larger tumor they originally found. The important factor is that the tumor cells did not spread to anywhere outside the removed breast. You are perfectly correct that the verdict comes on elapsed time. The longer you waited for the absence of any outward symptoms, the more assurance you are getting "cured" and NED. Good luck to you. Yes, time will tell. Too bad that we cannot detect mets on single cancer cells. Even if we could, either the presence or absence of one cancer cell does not mean bad things are happening.
__________________
Ann
Stage 1 dx Sept 05
ER/PR positive HER2 +++ Grade 3
Invasive carcinoma 1 cm, no node involvement
Mastec Sept 05
Annual scans all negative, Oct 06
Postmenopause. Arimidex only since Sept 06, bone or muscle ache after 3 month
Off Arimidex, change to Femara 1/12-07, ache stopped
Sept 07 all tests negative, pass 2 year mark
Feb 08 continue doing well.
Sep 09 four year NED still on Femara.
|